✦ LIBER ✦

Evidence for clinical efficacy of mitomycin C in heavily pretreated ovarian cancer patients carrying germ-line BRCA1 mutation

✍ Scribed by Vladimir M. Moiseyenko,Vyacheslav A. Chubenko,Fedor V. Moiseyenko…

Book ID: 126363980
Publisher: Springer US
Year: 2014
Tongue: English
Weight: 196 KB
Volume: 31
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-014-0199-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

One in 10 ovarian cancer patients carry

One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden

✍ S. Malander; M. Ridderheim; A. Måsbäck; N. Loman; U. Kristoffersson; H. Olsson; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Randomized Phase III Study of Erlotinib

Randomized Phase III Study of Erlotinib Versus Observation in Patients With No Evidence of Disease Progression After First-Line Platin-Based Chemotherapy for Ovarian Carcinoma: A European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup Study

✍ Vergote, I. B.; Jimeno, A.; Joly, F.; Katsaros, D.; Coens, C.; Despierre, E.; Ma 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 189 KB